S. Rigatti

发表

S. Rigatti, 2017, Journal of insurance medicine.

All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.

S. Rigatti, R. MacKenzie, Stephen A. Freitas, 2017, Journal of insurance medicine.

Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.

S. Rigatti, R. Stout, 2019, Journal of insurance medicine.

Seroprevalence of SARS-CoV-2 in an Asymptomatic US Population

S. Rigatti, R. Stout, 2020 .

HIV and the Seroprevalence of SARS-CoV-2

S. Rigatti, R. Stout, 2021 .

Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020

S. Rigatti, R. Stout, 2021, JAMA network open.

Activity Level as a Mortality Predictor in a Population Sample after Typical Underwriting Exclusions and Laboratory Scoring.

S. Rigatti, R. Stout, 2020, Journal of insurance medicine.

All-Cause Mortality for Diabetics or Individuals with Hyperglycemia Applying for Life Insurance.

S. Rigatti, R. MacKenzie, Stephen A. Freitas, 2016, Journal of insurance medicine.

Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.

S. Rigatti, R. Stout, 2019, Journal of insurance medicine.

Association of Liver Function Tests with Mortality in an Insurance Applicant Population.

S. Rigatti, R. Stout, 2022, Journal of Insurance Medicine.

The Long QT Syndrome: A Review and Mortality Analysis.

S. Rigatti, 2015, Journal of insurance medicine.

SARS-CoV-2 Antibody Prevalence and Association with Routine Laboratory Values in a Life Insurance Applicant Population

S. Rigatti, R. Stout, 2020, medRxiv.

S. Rigatti, 2017, Journal of insurance medicine.

The Change in Seroprevalence in the US plus Puerto Rico between May and September of SARS-CoV-2 Antibody in the Asymptomatic Population

S. Rigatti, R. Stout, 2020, medRxiv.